Last reviewed · How we verify
Moderate to severe alopecia areata
Approved treatments
- Ritlecitinib 20 mg · Pfizer
- Chronic- PF-06480605 450 mg SC Q4W · Pfizer
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Moderate to severe alopecia areata patent landscape — cliff calendar, originator estates, attackable patents
- Moderate to severe alopecia areata treatment landscape brief
- Moderate to severe alopecia areata treatment updates RSS
Frequently asked questions about Moderate to severe alopecia areata
What drugs treat Moderate to severe alopecia areata?
Tracked treatments include Ritlecitinib 20 mg, Chronic- PF-06480605 450 mg SC Q4W.
What is the treatment for Moderate to severe alopecia areata?
Standard treatment for Moderate to severe alopecia areata includes Ritlecitinib 20 mg, Chronic- PF-06480605 450 mg SC Q4W. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Moderate to severe alopecia areata patent cliff · Moderate to severe alopecia areata CI report
- Treatment: Ritlecitinib 20 mg · Pfizer
- Treatment: Chronic- PF-06480605 450 mg SC Q4W · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing